A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

For patients with overweight or obesity and symptomatic knee osteoarthritis, the researchers found that the mean change in VAS pain was −31.3 and −18.9 mm in the metformin and placebo groups, ...

Sometimes, arthritis affects only one knee compartment. In these cases, your doctor may recommend a partial knee replacement, in which they will replace only the affected compartment. X-ray scan ...

THURSDAY, May 1, 2025 (HealthDay News) -- For patients with overweight or obesity and symptomatic knee osteoarthritis, metformin is associated with a greater improvement in knee pain than placebo, ...